Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Tooth Loss More Prevalent in Adults With Chronic Disease
THURSDAY, May 28, 2020 (HealthDay News) — Adults with severe chronic disease or with fair or poor general health have a higher prevalence of edentulism and severe tooth loss, according to research published in the May 29 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Genetic Data May Up Diagnostic Efficiency for Rheumatic Disease
THURSDAY, May 28, 2020 (HealthDay News) — Converting genotype information into an interpretable probability value for five different inflammatory arthritis-causing diseases could potentially improve the diagnostic efficiency of rheumatic disease, according to a study published in the May 27 issue of Science Translational Medicine.
9.5 Percent Uninsured in U.S. From January Through June 2019
WEDNESDAY, May 27, 2020 (HealthDay News) — A total of 9.5 percent of persons were uninsured from January through June 2019, according to a report published online May 28 by the National Center for Health Statistics.
Links Found Between Leaders of Medical Associations, Industry
THURSDAY, May 28, 2020 (HealthDay News) — There are extensive financial relationships between leaders of U.S. professional medical associations and industry, according to a study published online May 27 in The BMJ.
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity to conduct telehealth-based outpatient visits, while only one in four had tele-intensive care unit (tele-ICU) capabilities, according to a research letter published online April 30 in the Annals of Internal Medicine.
Biomechanical Footwear May Aid Knee Osteoarthritis Outcomes
FRIDAY, May 22, 2020 (HealthDay News) — Use of biomechanical footwear is associated with an improvement in pain among patients with knee osteoarthritis at 24 weeks of follow-up, although the improvements are of uncertain clinical importance, according to a study published in the May 12 issue of the Journal of the American Medical Association.
ACR Updates Guideline for Management of Gout
THURSDAY, May 21, 2020 (HealthDay News) — In an updated American College of Rheumatology guideline, published online May 11 in Arthritis Care & Research, recommendations are presented for the management of gout.
Melanoma Risk From Biologic Therapy Remains Uncertain
THURSDAY, May 21, 2020 (HealthDay News) — Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a review published online May 20 in JAMA Dermatology.
Spending on Primary Care Continues to Lag in the U.S.
TUESDAY, May 19, 2020 (HealthDay News) — Spending on inpatient services, specialty care, and prescriptions together accounted for about two-thirds of the increase in total U.S. health care spending from 2002 to 2016, according to a research letter published online May 18 in JAMA Internal Medicine.
Burnout Comparable Between Millennial, Gen X Residents, Fellows
TUESDAY, May 19, 2020 (HealthDay News) — Millennial and Generation X medical residents and fellows experience similar rates of burnout and have similar levels of empathy, according to a study published online May 5 in Academic Psychiatry.
Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib
MONDAY, May 18, 2020 (HealthDay News) — For patients with atrial fibrillation (AF), the risk for osteoporotic fracture appears to be lower with direct oral anticoagulant (DOAC) use compared with warfarin use, according to a study published online May 19 in the Annals of Internal Medicine.
Guidance Issued for Osteoporosis Management During COVID-19
FRIDAY, May 15, 2020 (HealthDay News) — In a joint guidance document issued by the American Society for Bone and Mineral Research, American Association of Clinical Endocrinologists, Endocrine Society, European Calcified Tissue Society, and National Osteoporosis Foundation, recommendations are presented for the management of osteoporosis during the COVID-19 pandemic.
Most Physicians Have Seen False-Negative COVID-19 Test Results
MONDAY, May 18, 2020 (HealthDay News) — Most physicians believe they have seen false-negative results for a COVID-19 diagnostic test, according to the results of a recent survey.
Burden of Osteoarthritis Increasing in Most Countries
WEDNESDAY, May 13, 2020 (HealthDay News) — The burden of osteoarthritis (OA) is increasing in most countries, according to a study published online May 12 in Annals of the Rheumatic Diseases.
Anakinra May Reduce Systemic Inflammation in COVID-19
MONDAY, May 11, 2020 (HealthDay News) — High-dose anakinra, a recombinant interleukin-1 (IL-1) receptor antagonist, is associated with improved clinical outcomes for patients with COVID-19, acute respiratory distress syndrome (ARDS), and hyperinflammation, according to a study published online May 7 in The Lancet Rheumatology.
Long-Term Physical Activity Not Tied to Knee Arthritis
FRIDAY, May 8, 2020 (HealthDay News) — There is no association between long-term strenuous physical activity participation and incident radiographic knee osteoarthritis (KOA), according to a study published online May 4 in JAMA Network Open.
ATS Issues Guideline on the Diagnosis of Sarcoidosis
MONDAY, May 4, 2020 (HealthDay News) — In an official American Thoracic Society clinical practice guideline, published online April 15 in the American Journal of Respiratory and Critical Care Medicine, recommendations are presented for the detection and diagnosis of sarcoidosis.
Copyright © 2020 ScoutNews, LLC. All rights reserved.